Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 20/20 | 1.00 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.87 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.87 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.87 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.53 |
| ▸ | MTOR | P42345 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28601913 | 0.99 | PIK3CA (1.00) | PIK3CAPIK3CDPIK3CBPIK3CGPIK3R1 | |
| SCHEMBL30011234 | 0.93 | PIK3CA (1.00) | PIK3CAPIK3CDPIK3CBPIK3CGPIK3R1 | |
| SCHEMBL29969992 | 0.85 | PIK3CA (0.73) | PIK3CAPIK3CDPIK3CBPIK3CGPIK3R1 | |
| SCHEMBL28611076 | 0.84 | PIK3CA (1.00) | PIK3CAPIK3CDPIK3CBPIK3CG | |
| SCHEMBL28606396 | 0.84 | PIK3CA (1.00) | PIK3CAPIK3CDPIK3CBPIK3CG | |
| SCHEMBL29970025 | 0.83 | PIK3CA (0.81) | PIK3CAPIK3CDPIK3CBPIK3CGPIK3R1 | |
| SCHEMBL28599149 | 0.83 | PIK3CA (0.81) | PIK3CAPIK3CDPIK3CBPIK3CGPIK3R1 | |
| SCHEMBL29970518 | 0.83 | PIK3CA (0.83) | PIK3CAPIK3CDPIK3CBPIK3CG | |
| SCHEMBL28611073 | 0.82 | PIK3CA (1.00) | PIK3CAPIK3CDPIK3CBPIK3CG | |
| SCHEMBL28617236 | 0.82 | PIK3CA (0.78) | PIK3CAPIK3CDPIK3CBPIK3CG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022242321-A1 | PI3Kα SELECTIVE INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 中国药科大学 | 2022-11-24 | — | — | WO | disclosed |